[Metabolic syndrome and prostate cancer]
B J Schmitz-Dräger1, G Lümmen, E Bismarck
1Urologie, EuromedClinic, Europa-Allee 1, 90763 Fürth, Deutschland. bsd@euromed.de
Der Urologe. Ausg. A
|March 16, 2013
Summary
Metabolic syndrome (MS) components like high triglycerides and insulin-like growth factor 1 may predict aggressive prostate cancer (PCA). However, the complex relationship between MS and PCA requires further investigation for effective patient management.
Area of Science:
- Urooncology
- Metabolic Diseases
- Oncology
Background:
- The link between metabolic syndrome (MS) and prostate cancer (PCA) is complex due to MS being an ill-defined condition.
- Existing studies suggest correlations, but conclusive evidence is lacking.
Purpose of the Study:
- To explore the multifaceted relationship between metabolic syndrome and prostate cancer.
- To assess the prognostic value of MS components in prostate cancer patients.
Main Methods:
- Review of current literature on metabolic syndrome and prostate cancer.
- Analysis of studies investigating specific MS components (e.g., triglycerides, cholesterol, IGF-1, insulin) and their association with PCA risk and prognosis.
Main Results:
- Diabetes may show an inverse relationship with PCA.
- Elevated triglycerides, cholesterol, and IGF-1 may predict high-grade PCA.
- MS and high insulin levels are independent predictors of poor prognosis in metastatic PCA.
Conclusions:
- The relationship between MS and PCA is intricate, with some components potentially indicating higher risk or poorer outcomes.
- MS development and associated cardiovascular risks are increasingly relevant for patients undergoing PCA hormone therapy.
- Prevention, early detection, and management of MS are critical clinical challenges in urooncology.
More Related Videos
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.